Recombinant Botulinum Toxin Type A(JHM BioPharma)

重组A型肉毒毒素（君合盟生物）

Report date: 2026/01/07 14:01:00

Base Information

Drug NameRecombinant Botulinum Toxin Type A(JHM BioPharma)

Drug Alias NameEveotoxJHM03JHM-03

ClassificationBiologics > Protein drugs > ToxinNatural product/Extract > Microbial extract

Mechanisms of ActionSynaptosomal-associated protein 25 inhibitors

TargetsSynaptosomal-associated protein 25

Therapy Area/IndicationsNasolabial fold wrinklesUpper and lower limb spasticityGlabellar lines +[7]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaPhase 3 Clinical

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsUpper and lower limb spasticityGlabellar linesUpper limb spasticity +[6]

Inactive IndicationsNasolabial fold wrinkles

ATC CodeM03AX01